 FSD Pharma Inc. Nasdaq: HUGE CSE: HUGE.CN FSD Pharma or the Company today announced that it has entered into an Equity Distribution Agreement dated July 10, 2020 the Sales Agreement with A.G.P.Alliance Global Partners the Sales Agent. Under the Sales Agreement the Company may, at its discretion and from time-to-time during the term of the Sales Agreement, sell, through the Sales Agent, Class B Subordinate Voting Shares of the Company the Class B Shares for aggregate gross proceeds to the Company of up to US20.0 million the Offering. Sales of Class B Shares will be made through at-the-market distributions as defined in the Canadian Securities Administrators National Instrument 44-102-Shelf Distributions, including sales made directly on the Nasdaq Capital Market Nasdaq, or any other recognized trading market upon which the Class B Shares are listed or quoted in the United States. No offers or sales of Class B Shares will be made in Canada on the Canadian Securities Exchange the CSE or other trading markets in Canada. 